Features
Latest World Pharmaceuticals Feature
The labels on drug packaging are one of the main drug/patient interfaces in...
> read more
Seeking value in serialization The concept of serialisation was primarily a response to the counterfeit drug challenge of the early 2000s. Though technological advances and regulatory development never fully...
Trial and error Covid-19 transformed clinical trials practically overnight, with remote testing and quicker approvals suddenly becoming a reality the world over. These shifts aren’t hard to...
A harmony of interests Data sets obtained through collaboration across multiple countries are an important way to strengthen research findings, and in some cases can be necessary to study rare diseases due...
The right temperature Temperature control can be the difference between a supply of usable products and a shortfall that delays a trial and increases the overall cost for sponsors. This level of risk...
Backwards about moving forwards Clinical trials have long been famous for their sophistication and lengthy timespans. But traditionally, organisers have paid less attention to what happens once the research is done...
Flex and adapt: the new onsite model As some companies move part of their workforce back into the office to afford workers the flexibility to work in a hybrid model, new skills and considerations must be developed to...
Data is king The advent of dedicated software has made it easier to keep track of the large volume of information involved in running a clinical trial. Yet the multiplicity of requirements...
Track and trace There is nothing like a pandemic for demonstrating the necessity for serialisation, interoperability, and more advanced analytics and tracking. Tim Gunn asks Rob Handfield, the...
Outsource and intake For decades, pharmaceutical companies have relied on contract development and manufacturing companies (CDMOs) to develop drugs. But though these third-party contractors proved their...
Double agents Looking at a vial of liquid or a solid pill, it’s easy to see pharmaceuticals as simple objects rather than a complex array of chemicals and raw materials, delicately balanced to...
The struggle to supply Pharmaceutical supply chains are still reacting to the pressures of the pandemic, though they have mostly held steady and avoided many of the potential risks. The stresses placed...
Good things, small packages Containers have been an inescapable part of the pharma supply chain forever – but it’s only with the rise of sophisticated new treatments, and the consequences of the pandemic,...
A glass act Glass has been the most popular primary packaging choice for drug makers for centuries, a combination of its formulation compatibility and low permeability. But the choice of...
Better sterile than sorry Sterility throughout the manufacturing process is something no pharmaceutical company can overlook, both from a regulatory and a customer care standpoint. That said, the actual...
The digital health game Some of the most ground-breaking results come when technologies are combined with the same ambition in mind. Advances in pharmaceuticals will continue to change people’s lives,...
Down the hatch Vaccination continues to be our best defence against the morbidity and mortality caused by Covid-19, but with the imperative to ‘boost’ the number of antibodies by giving multiple...
Subject to requirements Clinical trial materials each have unique packaging requirements, and there are also a number of processes and systems to consider that can help to minimise delays and ensure a...
Choosing the right central lab Central laboratories have become an important part of running global clinical trials in Europe and the US. With the rapid increase in the number of studies conducted in China and...
Rise to the challenge Running a clinical trial can be a difficult process at the best of times, but the level of complexity can be orders of magnitude higher when it comes to rare disease research....
View all features A-Z
